Prescribing in care homes: the role of the geriatrician

Therapeutic Advances in Chronic Disease - Tập 2 Số 6 - Trang 353-358 - 2011
Eileen Burns1,2, Nuala McQuillan1,2
1St James's Hospital Leeds -Medicine for the Elderly, Beckett Street, Leeds LS9 7TF, UK
2St James's Hospital Leeds -Medicine for the Elderly, Leeds, UK

Tóm tắt

Large numbers of frail elderly people spend some time of their lives in care homes. Increasing age is associated with altered physiology, multiple diagnoses and complex comorbidity, and polypharmacy. Those living in care homes often take larger numbers of medications than those who live in the community and the risk of morbidity as a direct or indirect result of medications is high. Many methods have been suggested to revise the number and type of medications prescribed for individuals at risk of adverse drug reactions (ADRs), both in the community and in hospital with variable success and implementation. Assessment of prescribed and nonprescribed medications by pharmacists, nurses and general practitioners all have a role in optimizing therapeutics with evidence that improved prescribing can reduce the risk of ADRs. In conjunction with these professionals, community geriatricians undertaking a comprehensive geriatric assessment can reduce the number of medications prescribed or optimize therapy where there may be underprescribing (e.g. in depression), thereby reducing the overall risk of hospital admission ADRs.

Từ khóa


Tài liệu tham khảo

Alexopoulos G.S., 2004, J Clin Psychiatry, 65, 5

10.1016/j.ejim.2007.06.030

Bebbington A., 2001, Care Homes for Older People. Vol. 2: Admission, Needs and Outcomes The 1995/96 National Longitudinal Survey of Publicly-funded Admissions

10.1001/archinte.1991.00400090107019

Comas-Herrera A., 2001, Projections of demand for residential care for older people in England to 2020

10.2174/092986710790416326

10.2165/00003088-197601040-00003

10.1093/ageing/afh213

10.1016/j.amjopharm.2005.01.001

10.4140/TCP.n.2008.324

10.1001/archinte.163.22.2716

10.2165/00002018-200831060-00009

10.1093/ageing/afl131

10.1192/apt.8.3.198

Garcia R.M., 2006, J Fam Pract, 55, 305

10.7326/0003-4819-146-11-200706050-00006

10.1016/S0140-6736(84)90775-X

10.1111/j.1532-5415.1987.tb01395.x

10.1345/aph.1G585

10.1016/j.amjmed.2006.07.045

10.1111/j.1472-8206.2007.00473.x

10.2147/tcrm.1.2.151.62914

10.1007/s00228-003-0679-y

10.1136/qhc.12.4.280

10.1345/aph.1M147

10.2165/11318890-000000000-00000

10.1093/ageing/29.5.451

Lapsley R., 1988, Pharm J, 240, 688

10.1001/archinte.165.1.68

Lauritzen J., 1993, Dan Med Bull, 40, 479

10.2165/00003088-199834050-00003

10.1124/pr.56.2.4

McLeod P., 1997, CMAJ, 156, 385

10.1136/bmj.314.7076.266

10.1001/archinte.160.18.2825

10.1159/000022097

Department of Health, 2001, National Services Framework for Older People

10.1016/j.amjopharm.2006.03.002

N.H.S. Information Centre, 2010, Adult Social Care Statistics. Information and Guidance on Adult Social Care Combined Activity Return

10.1016/j.amjopharm.2009.07.001

10.1136/bmj.39049.706493.55

10.1093/ageing/afm189

10.1111/j.1532-5415.2008.02119.x

10.3109/08923970903468847

10.2165/00002512-200522090-00005

10.1186/1472-6904-7-9

10.1136/bmj.329.7456.15

10.1161/01.STR.32.6.1385

10.1046/j.1365-2125.2003.01875.x

10.1016/j.amjmed.2003.10.031

10.2105/AJPH.87.3.404

10.2165/00002018-200629020-00006

10.1007/s002280050669

10.3109/08923970903468847

10.1136/pgmj.71.838.466

Wiffen P., 2002, Bandolier Extra, 1

10.1111/j.1365-2648.2008.04656.x

10.1111/j.1532-5415.1995.tb06098.x

10.1016/j.jamda.2007.04.002

10.1258/jrsm.2010.100113

10.1093/ageing/afl075

10.1001/jama.286.22.2823

Thông tin
Thông tin xuất bản

Therapeutic Advances in Chronic Disease

Tập 2 Số 6

353-358

Thông tin tác giả